Mid-Year Drug Trend Report

2019 - 2020 (6 month comparison)

Drug Trend Report


The Xevant mid-year Drug Trend Report provides detailed insights into the key drivers of cost changes between the first half of 2019 and the first half of 2020. This independently derived report highlights the impact of each of the following individually separated sources of increases and decreases on pharmacy claims cost: PBM Discounts, Drug Inflation, Drug Mix, Utilizer Changes, and Intensity. The report is presented using "per utilizer per month" figures instead of using totals in order to normalize and deidentify the data. 

Total Cost Change


8.1% Increase

1st Half 2019


1st Half 2020


The analysis comprised within this report was derived from a large, broad spectrum of nationwide, commercial, and self-insured, deidentified pharmacy claims data. Xevant's extensive data warehouse is one of the largest independently maintained pharmacy claims datasets obtained from a wide range of claims administrators including PBMs, TPAs, Payers, and consultants representing employers of all sizes.

Next: Trend Driver Analysis

Click the right arrow to advance

Get Your Own Customized Drug Trend Analysis 

Have a quick call with one of our experts to learn more about getting a detailed analysis of the core drug cost drivers.

Thanks for submitting! A Xevant representative will be in touch shortly to discuss your custom report.


Jace Garfield

VP, Analytics, Xevant 

  • Grey LinkedIn Icon

Nick Conway

SVP, Analytics, NFP 

  • Grey LinkedIn Icon

Brandon Newman

CEO, Xevant

  • Grey LinkedIn Icon